Rapid tests are manual tests based on an antigen-antibody reaction. They provide results within 10 to 30 minutes, depending on the product being used.
They help to reduce the time required to treat patients and enable appropriate care to be prescribed without delay.
Their low cost and ease of use make them ideal for users without access to a laboratory.
They are also used for screening in physician offices and at the patient’s point of care in hospitals.
bioMérieux develops two ranges of rapid tests:
- The BIONEXIA® range is used for the rapid detection of Influenza A and B, Legionella pneumophila, Streptococcus throat infections, gastritis due to Helicobacter pylori and more recently, viral gastroenteritis caused by noroviruses, rotaviruses and adenoviruses.
- The VIKIA® range features a novel and robust design making it ideal for use by medical staff in all situations and all types of laboratory. The VIKIA® range is especially well-suited to resource-limited countries for the diagnosis of infectious diseases such as malaria and hepatitis B, and HIV infections. The VIKIA® HIV test has been pre-qualified by the WHO and the VIKIA® HBs ag test is undergoing prequalification review by the WHO.
Find out more: bioMérieux FIRST LINE BIOLOGY®